Fluids from immune privileged sites endow macrophages with the capacity to induce antigen‐specific immune deviation via a mechanism involving transforming growth factor‐β
- 1 April 1992
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 22 (4) , 1031-1036
- https://doi.org/10.1002/eji.1830220423
Abstract
The eye, brain, and fetoplacental unit within the pregnant uterus are immunologically privileged sites that contain unique fluids with suspected immunoinhibitory properties. Aqueous humor, which is normally present within the anterior chamber (AC) of the eye, has been shown to suppress antigen-driven T cell activation, and to contain significant amounts of transforming growth factor β-2 (TGF-β). Antigens injected into the AC of normal mice induce a deviant form of systemic immunity, termed anterior chamber-associated immune deviation (ACAID), which is characterized by a selective inability to display antigen-specific delayed hypersensitivity. It has recently been reported that eye-derived macrophages appear in the blood following AC injection of a soluble antigen, and that these cells can induce antigen-specific ACAID when injected into naive, syngeneic recipients. Moreover, antigen-pulsed peritoneally derived macrophages that are exposed in vitro to aqueous humor, supernatants of cultured iris and ciliary body cells (I/CD), or TGF-β have been found to assume ACAID-inducing properties. In the present experiments, amniotic fluid and cerebrospinal fluid from mice, rats and humans, as well as supernatants from cultured I/CB cells, have been examined for their capacity to confer ACAID-inducing properties on peritoneal macrophages. It was found that each of these biologic fluids, but neither normal mouse serum nor rat thoracic duct lymph, was able to endow antigen-pulsed peritoneal macrophages with ACAID-inducing properties. Moreover, fluids from these immune privileged sites were found to contain latent and/or active TGF-β, as determined by bioassay, using neutralizing anti-TGF-β antibodies. It is concluded (a) that the immune privileged states of the eye, the brain, and the fetoplacental unit share common features, and possess unique fluids with a similar capacity to force macrophages to present antigens in a “deviant” manner and (b) that this capacity is mediated, at least in part, by TGF-β. These results are discussed in terms of the potential physiologic and pathophysiologic significance of immune privilege in these three specialized tissues.Keywords
This publication has 26 references indexed in Scilit:
- Studies on the induction of anterior chamber‐associated immune deviation (ACAID) III. Induction of ACAID depends upon intraocular transforming growth factor‐βEuropean Journal of Immunology, 1992
- Myelin basic protein infused into cerebrospinal fluid suppresses experimental autoimmune encephalomyelitisJournal of Neuroimmunology, 1991
- Characterization of specific T helper cell activity in mice bearing alloantigenic tumors in the anterior chamber of the eyeEuropean Journal of Immunology, 1991
- THE ROLE OF MHC AND NON-MHC ANTIGENS IN THE REJECTION OF INTRACEREBRAL ALLOGENEIC NEURAL GRAFTSTransplantation, 1989
- Immunodetection and quantitation of the two forms of transforming growth factor‐beta (TGF‐β1 and TGF‐β2) secreted by cells in cultureJournal of Cellular Physiology, 1989
- Immunologic privilege in the eye and the fetusImmunology Today, 1987
- An in vivo and in vitro analysis of systemic immune function in mice with histologic evidence of neural transplant rejectionJournal of Neuroscience Research, 1987
- Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens.The Journal of Experimental Medicine, 1980
- The transplantation of normal tissues: with special reference to auto- and homotransplants of thyroid and spleen in the anterior chamber of the eye, and subcutaneously, in guinea-pigsPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1950